American Journal of Hypertension · 2001 · 49 citations · 16 references
Life SciencesGeneticsMolecular GeneticsCardiovascular GeneticsHuman GeneticsMedical GeneticsBlood Pressure RegulationHypertensive DisordersReceptor PolymorphismsAdrenergic Receptor GeneticsBeta-adrenergic Receptor PolymorphismsBlood PressureBlood Pressure GeneticsFamilial Relative RiskGenetic Determinants Of HypertensionRelative Risk EstimationTransversion Mutations
BACKGROUND: Several studies implicate polymorphisms in the human beta-adrenergic receptor gene (ADRB2) in the susceptibility to hypertension. We sought to replicate these results in a population of Chinese origin primarily from Taiwan and the San Francisco Bay area. METHODS: We genotyped >800 hypertensive subjects and individuals with low-normal blood pressure that were derived largely from the same families as the hypertensive patients for three polymorphisms in the ADRB2 gene: a C/T transition at position 47 (C-47T) in the 5' leader cistron; another C/T transition that results in a glycine/ arginine substitution at codon 16 (Gly16Arg), and a G/C transversion that causes a glutamate/glutamine substitution at codon 27 (Glu27Gln). RESULTS: The Gly16Arg was significantly associated with hypertension (P < .03). Under a dominant model, for hypertension the relative risk for the Gly/Gly and Gly/Arg genotypes versus the Arg/Arg genotype was 1.35 (95% confidence limits [CL] 1.08, 1.70); for low-normal blood pressure the relative risk was 0.79 (95% CL 0.66, 0.94). This polymorphism explained approximately 1% of the variance in systolic and diastolic blood pressures in our study population. There was no evidence of association between the C-47T and Glu27Gln polymorphisms and hypertension in this population. CONCLUSIONS: The Glyl6 allele in the beta2-adrenergic receptor gene is a susceptibility allele for essential hypertension in a population of Chinese origin.
16
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Michaela Modan, Hillel Halkin, Shlomo Almog et al. · Journal of Clinical Investigation · 1985 · 1.5K citations · Full text
Medicine, Endocrinology, Diabetology +13
Targeted Disruption of the β2 Adrenergic Receptor Gene
Andrzej Chruscinski, Daniel Rohrer, Eric Schauble et al. · Journal of Biological Chemistry · 1999 · 333 citations · Full text
Medicine, Cardiology, Pharmacology +11
Clustering of cardiovascular risk factors in confirmed prehypertensive individuals.
Steven M. Haffner, Ele Ferrannini, Helen P. Hazuda et al. · Hypertension · 1992 · 204 citations · Full text
Medicine, Cardiology, Endocrinology +14